Literature DB >> 29778616

Routine portal vein resection for pancreatic adenocarcinoma shows no benefit in overall survival.

Fritz Klein1, Finja Berresheim2, Matthäus Felsenstein2, Thomas Malinka2, Uwe Pelzer3, Timm Denecke4, Johann Pratschke2, Marcus Bahra2.   

Abstract

BACKGROUND: Extended pancreatic resections including resections of the portal (PV) may nowadays be performed safely. Limitations in distinguishing tumor involvement from inflammatory adhesions however lead to portal vein resections (PVR) without evidence of tumor infiltration in the final histopathological examination. The aim of this study was to analyze the impact of these "false negative" resections on operative outcome and long-term survival.
METHODS: 40 patients who underwent pancreatic resection with PVR for pancreatic adenocarcinoma (PA) without tumor infiltration of the PV (PVR-group) were identified. In a 1:3 match these patients were compared to 120 patients after standard pancreatic resection without PVR (SPR-group) with regard to operative outcome and overall survival.
RESULTS: Survival analysis revealed that median survival was significantly shorter in the PVR group (311 days) as compared to the SPR group (558 days), (p = 0.0011, hazard ratio 1.98, 95% CI: 1.31-2.98). Also postoperative complications ≥ Clavien III occurred significantly more often in the PVR group (37.5% vs. 20.8%).
CONCLUSIONS: Radical resection affords the best chance for long-term survival in patients with PA. Based on the results of this study a routine resection of the PV as recently proposed may however not be recommended.
Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Pancreatic adenocarcinoma; Pancreatic resection; Routine portal vein resection; Surgical radicality; True tumor infiltration

Mesh:

Year:  2018        PMID: 29778616     DOI: 10.1016/j.ejso.2018.05.002

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  3 in total

1.  Analysis of outcomes and predictors of long-term survival following resection for retroperitoneal sarcoma.

Authors:  Thomas Malinka; Maxim Nebrig; Fritz Klein; Johann Pratschke; Marcus Bahra; Andreas Andreou
Journal:  BMC Surg       Date:  2019-06-10       Impact factor: 2.102

Review 2.  Hepatobiliary-pancreatic surgery for patients with a prepancreatic postduodenal portal vein: a case report and literature review.

Authors:  Taku Higashihara; Yasuhiro Morita; Tatsuya Hayashi; Makoto Takahashi; Norikazu Yogi; Shu Sasaki; Daren Zhou
Journal:  BMC Surg       Date:  2022-02-13       Impact factor: 2.102

Review 3.  What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?

Authors:  Julie Navez; Christelle Bouchart; Diane Lorenzo; Maria Antonietta Bali; Jean Closset; Jean-Luc van Laethem
Journal:  Ann Surg Oncol       Date:  2021-01-21       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.